Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Triple Drug Therapy for Melanoma
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial is testing a combination of three drugs to treat melanoma. The drugs will be given for different lengths of time depending on whether the patient is in the induction or maintenance phase of the trial. The trial will assess the safety and tolerability of the combination and the pharmacodynamic activity of one of the drugs.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.